Pexidartinib Provides Modest Pain Relief in Patients With Tenosynovial Giant Cell Tumor: Results From ENLIVEN

Pexidartinib improves physical functioning and stiffness in patients with tenosynovial giant cell tumor: results from the ENLIVEN randomized clinical trial

(2021) Michiel Van De Sande et al.   Acta Orthopaedica

The diffuse-type tenosynovial giant cell tumor (dt-TGCT) patient journey: a prospective multicenter study

(2021) Nicholas M. Bernthal et al.   Orphanet Journal of Rare Diseases

Long-term clinical activity, safety and patient-reported quality of life for emactuzumab-treated patients with diffuse-type tenosynovial giant-cell tumour

(2020) Philippe A. Cassier et al.   EUROPEAN JOURNAL OF CANCER

Surgical Treatment of Localized-Type Tenosynovial Giant Cell Tumors of Large Joints

(2019) M.J.L. Mastboom et al.   JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME

Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial

(2019) William D Tap et al.   LANCET

Surgical outcomes of patients with diffuse-type tenosynovial giant-cell tumours: an international, retrospective, cohort study

(2019) Monique J L Mastboom et al.   LANCET ONCOLOGY

Long-term efficacy of imatinib mesylate in patients with advanced Tenosynovial Giant Cell Tumor

(2019) F. G. M. Verspoor et al.   Scientific Reports

The Placebo Effect in Pain Therapies

(2018) Luana Colloca   Annual Review of Pharmacology and Toxicology

Missing data in clinical trials: control-based mean imputation and sensitivity analysis

(2017) Devan V. Mehrotra et al.   PHARMACEUTICAL STATISTICS

Patient-reported Symptoms of Tenosynovial Giant Cell Tumors

(2016) Heather L. Gelhorn et al.   CLINICAL THERAPEUTICS

Tenosynovial giant cell tumour/pigmented villonodular synovitis: Outcome of 294 patients before the era of kinase inhibitors

(2015) Emanuela Palmerini et al.   EUROPEAN JOURNAL OF CANCER

Effects of Cabozantinib on Pain and Narcotic Use in Patients with Castration-resistant Prostate Cancer: Results from a Phase 2 Nonrandomized Expansion Cohort

(2015) Ethan Basch et al.   EUROPEAN UROLOGY

Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell Tumor

(2015) William D. Tap et al.   NEW ENGLAND JOURNAL OF MEDICINE

Analysis of Longitudinal Trials with Protocol Deviation: A Framework for Relevant, Accessible Assumptions, and Inference via Multiple Imputation

(2013) James R. Carpenter et al.   Journal of Biopharmaceutical Statistics

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER

Interpreting the Clinical Importance of Treatment Outcomes in Chronic Pain Clinical Trials: IMMPACT Recommendations

(2007) Robert H. Dworkin et al.   JOURNAL OF PAIN